Skip to main content
Erschienen in: Current Hypertension Reports 9/2014

01.09.2014 | Hypertension and the Brain (S Stocker, Section Editor)

Central Nervous System Dysfunction in Obesity-Induced Hypertension

verfasst von: Geoffrey A. Head, Kyungjoon Lim, Benjamin Barzel, Sandra L. Burke, Pamela J. Davern

Erschienen in: Current Hypertension Reports | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

The activation of the sympathetic nervous system is a major mechanism underlying both human and experimental models of obesity-related hypertension. While insulin and the adipokine leptin have long been thought to contribute to obesity-related neurogenic mechanisms, the evidence is now very strong that they play a major role, shown particularly in animal studies using selective receptor antagonists. There is not just maintenance of leptin’s sympatho-excitatory actions as previously suggested but considerable amplification particularly in renal sympathetic nervous activity. Importantly, these changes are not dependent on short-term elevation or reduction in plasma leptin or insulin, but require some weeks to develop indicating a slow “neural adaptivity” within hypothalamic signalling. These effects can be carried across generations even when offspring are raised on a normal diet. A better understanding of the underlying mechanism should be a high research priority given the prevalence of obesity not just in the current population but also for future generations.
Literatur
1.
Zurück zum Zitat Alwan A, World Health Organization. Global Status Report on Noncommunicable Diseases. 2010. Alwan A, World Health Organization. Global Status Report on Noncommunicable Diseases. 2010.
2.
Zurück zum Zitat Garrison RJ, Kannel WB, Stokes 3rd J, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987;16(2):235–51.PubMedCrossRef Garrison RJ, Kannel WB, Stokes 3rd J, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987;16(2):235–51.PubMedCrossRef
3.
4.
Zurück zum Zitat Rahmouni K, Haynes WG, Mark AL. Cardiovascular and sympathetic effects of leptin. Curr Hypertens Rep. 2002;4(2):119–25.PubMedCrossRef Rahmouni K, Haynes WG, Mark AL. Cardiovascular and sympathetic effects of leptin. Curr Hypertens Rep. 2002;4(2):119–25.PubMedCrossRef
5.
Zurück zum Zitat Mark AL. Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol. 2013;305(6):R566–81.PubMedCrossRef Mark AL. Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol. 2013;305(6):R566–81.PubMedCrossRef
6.
Zurück zum Zitat Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285(23):17271–6.PubMedCentralPubMedCrossRef Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285(23):17271–6.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat da Silva AA, do Carmo J, Dubinion J, Hall JE. The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep. 2009;11(3):206–11.PubMedCentralPubMedCrossRef da Silva AA, do Carmo J, Dubinion J, Hall JE. The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep. 2009;11(3):206–11.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Hall JE, Zappe DH, AlonsoGalicia M, Granger JP, Brands MW, Kassab SE. Mechanisms of obesity-induced hypertension. News Physiol Sci. 1996;11:255–61. Hall JE, Zappe DH, AlonsoGalicia M, Granger JP, Brands MW, Kassab SE. Mechanisms of obesity-induced hypertension. News Physiol Sci. 1996;11:255–61.
9.
Zurück zum Zitat Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. NEJM. 1978;298(23):1295–301.PubMedCrossRef Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. NEJM. 1978;298(23):1295–301.PubMedCrossRef
10.
Zurück zum Zitat Bray GA. Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J Nutr. 1991;121(8):1146–62.PubMed Bray GA. Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J Nutr. 1991;121(8):1146–62.PubMed
11.
Zurück zum Zitat McAllen RM, May CN, Campos RR. The supply of vasomotor drive to individual classes of sympathetic neuron. Clin Exp Hypertens. 1997;19(5–6):607–18.PubMedCrossRef McAllen RM, May CN, Campos RR. The supply of vasomotor drive to individual classes of sympathetic neuron. Clin Exp Hypertens. 1997;19(5–6):607–18.PubMedCrossRef
12.
Zurück zum Zitat Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96(10):3423–9.PubMedCrossRef Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96(10):3423–9.PubMedCrossRef
13.
Zurück zum Zitat Abate NI, Mansour YH, Tuncel M, Arbique D, Chavoshan B, Kizilbash A, et al. Overweight and sympathetic overactivity in black Americans. Hypertension. 2001;38(3):379–83.PubMedCrossRef Abate NI, Mansour YH, Tuncel M, Arbique D, Chavoshan B, Kizilbash A, et al. Overweight and sympathetic overactivity in black Americans. Hypertension. 2001;38(3):379–83.PubMedCrossRef
14.
Zurück zum Zitat Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E, et al. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension. 2007;50(5):862–8.PubMedCrossRef Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E, et al. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension. 2007;50(5):862–8.PubMedCrossRef
15.
Zurück zum Zitat Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106(20):2533–6.PubMedCrossRef Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106(20):2533–6.PubMedCrossRef
16.
Zurück zum Zitat Grassi G, Seravalle G, DellOro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension. 2000;36(4):538–42.PubMedCrossRef Grassi G, Seravalle G, DellOro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension. 2000;36(4):538–42.PubMedCrossRef
17.
Zurück zum Zitat Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, et al. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens. 2007;25(7):1411–9.PubMedCrossRef Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, et al. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens. 2007;25(7):1411–9.PubMedCrossRef
18.
Zurück zum Zitat Alvarez GE, Ballard TP, Beske SD, Davy KP. Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol. 2004;287(1):H414–8.PubMedCrossRef Alvarez GE, Ballard TP, Beske SD, Davy KP. Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol. 2004;287(1):H414–8.PubMedCrossRef
19.
Zurück zum Zitat Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22(12):2363–9.PubMedCrossRef Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22(12):2363–9.PubMedCrossRef
20.
Zurück zum Zitat Lambert EA, Rice T, Eikelis N, Straznicky NE, Lambert GW, Head GA et al. Sympathetic activity and cardiovascular risk in non-diabetic severely obese patients: The effect of 10 % weight loss. Am J Hypertens. 2014:In press. Lambert EA, Rice T, Eikelis N, Straznicky NE, Lambert GW, Head GA et al. Sympathetic activity and cardiovascular risk in non-diabetic severely obese patients: The effect of 10 % weight loss. Am J Hypertens. 2014:In press.
21.
Zurück zum Zitat Straznicky NE, Lambert EA, Grima MT, Eikelis N, Richards K, Nestel PJ et al. The effects of dietary weight loss on indices of norepinephrine turnover: Modulatory influence of hyperinsulinemia. Obesity (Silver Spring). 2013. Straznicky NE, Lambert EA, Grima MT, Eikelis N, Richards K, Nestel PJ et al. The effects of dietary weight loss on indices of norepinephrine turnover: Modulatory influence of hyperinsulinemia. Obesity (Silver Spring). 2013.
22.
Zurück zum Zitat Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, et al. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension. 2007;49(1):27–33.PubMedCrossRef Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, et al. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension. 2007;49(1):27–33.PubMedCrossRef
23.
Zurück zum Zitat Carlson SH, Shelton J, White CR, Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension. 2000;35(1 Pt 2):403–8.PubMedCrossRef Carlson SH, Shelton J, White CR, Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension. 2000;35(1 Pt 2):403–8.PubMedCrossRef
24.
Zurück zum Zitat Armitage JA, Burke SL, Prior LJ, Barzel B, Eikelis N, Lim K, et al. Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet. Hypertension. 2012;60:163–71.PubMedCrossRef Armitage JA, Burke SL, Prior LJ, Barzel B, Eikelis N, Lim K, et al. Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet. Hypertension. 2012;60:163–71.PubMedCrossRef
25.
Zurück zum Zitat Rahmouni K, Fath MA, Seo S, Thedens DR, Berry CJ, Weiss R, et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J Clin Invest. 2008;118(4):1458–67.PubMedCentralPubMedCrossRef Rahmouni K, Fath MA, Seo S, Thedens DR, Berry CJ, Weiss R, et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J Clin Invest. 2008;118(4):1458–67.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Rajapakse NW KF, Fernandez S, Evans RG, Head GA, Kaye DM. L-arginine transporters: a new treatment target in obesity induced hypertension? Hypertension, Abstract from the High Blood Pressure Research Council of Australia. 2013. Rajapakse NW KF, Fernandez S, Evans RG, Head GA, Kaye DM. L-arginine transporters: a new treatment target in obesity induced hypertension? Hypertension, Abstract from the High Blood Pressure Research Council of Australia. 2013.
27.••
Zurück zum Zitat Lim K, Burke SL, Head GA. Obesity related hypertension and the role of insulin and leptin in high fat fed rabbits. Hypertension. 2013;61(3):628–34. This landmark report demonstated that elevated blood pressure and renal sympathetic nerve activity induced by a high-fat diet for several weeks are predominantly mediated by delayed central sympathoexcitatory actions of the hormone leptin. Central actions of insulin contribute to a smaller proportion of the hypertension but independently of renal sympathetic activity. Two faculty of 1000 recommendations.PubMedCrossRef Lim K, Burke SL, Head GA. Obesity related hypertension and the role of insulin and leptin in high fat fed rabbits. Hypertension. 2013;61(3):628–34. This landmark report demonstated that elevated blood pressure and renal sympathetic nerve activity induced by a high-fat diet for several weeks are predominantly mediated by delayed central sympathoexcitatory actions of the hormone leptin. Central actions of insulin contribute to a smaller proportion of the hypertension but independently of renal sympathetic activity. Two faculty of 1000 recommendations.PubMedCrossRef
28.
Zurück zum Zitat Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–32.PubMedCrossRef Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–32.PubMedCrossRef
29.
Zurück zum Zitat Frühbeck G. Peripheral actions of leptin and its involvement in disease. Nutr Rev. 2002;60(10 Pt 2):S47–55. discussion S68-84, 5–7.PubMedCrossRef Frühbeck G. Peripheral actions of leptin and its involvement in disease. Nutr Rev. 2002;60(10 Pt 2):S47–55. discussion S68-84, 5–7.PubMedCrossRef
30.
Zurück zum Zitat Haque MS, Minokoshi Y, Hamai M, Iwai M, Horiuchi M, Shimazu T. Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes. 1999;48(9):1706–12.PubMedCrossRef Haque MS, Minokoshi Y, Hamai M, Iwai M, Horiuchi M, Shimazu T. Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes. 1999;48(9):1706–12.PubMedCrossRef
31.
Zurück zum Zitat Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100(2):270–8.PubMedCentralPubMedCrossRef Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100(2):270–8.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31(1 Pt 2):409–14.PubMedCrossRef Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31(1 Pt 2):409–14.PubMedCrossRef
33.
Zurück zum Zitat Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997;46(12):2040–3.PubMedCrossRef Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997;46(12):2040–3.PubMedCrossRef
34.
Zurück zum Zitat Dunbar JC, Lu H. Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res Bull. 1999;50(3):215–21.PubMedCrossRef Dunbar JC, Lu H. Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res Bull. 1999;50(3):215–21.PubMedCrossRef
35.
Zurück zum Zitat Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension. 1999;33(1 Pt 2):542–7.PubMedCrossRef Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension. 1999;33(1 Pt 2):542–7.PubMedCrossRef
36.
Zurück zum Zitat Li B, Shi Z, Cassaglia PA, Brooks VL. Leptin acts in the forebrain to differentially influence baroreflex control of lumbar, renal, and splanchnic sympathetic nerve activity and heart rate. Hypertension. 2013;61(4):812–9.PubMedCrossRef Li B, Shi Z, Cassaglia PA, Brooks VL. Leptin acts in the forebrain to differentially influence baroreflex control of lumbar, renal, and splanchnic sympathetic nerve activity and heart rate. Hypertension. 2013;61(4):812–9.PubMedCrossRef
37.
Zurück zum Zitat Warne JP, Alemi F, Reed AS, Varonin JM, Chan H, Piper ML, et al. Impairment of central leptin-mediated PI3K signaling manifested as hepatic steatosis independent of hyperphagia and obesity. Cell Metab. 2011;14(6):791–803.PubMedCentralPubMedCrossRef Warne JP, Alemi F, Reed AS, Varonin JM, Chan H, Piper ML, et al. Impairment of central leptin-mediated PI3K signaling manifested as hepatic steatosis independent of hyperphagia and obesity. Cell Metab. 2011;14(6):791–803.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Satoh N, Ogawa Y, Katsuura G, Numata Y, Tsuji T, Hayase M, et al. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes. 1999;48(9):1787–93.PubMedCrossRef Satoh N, Ogawa Y, Katsuura G, Numata Y, Tsuji T, Hayase M, et al. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes. 1999;48(9):1787–93.PubMedCrossRef
39.
Zurück zum Zitat Tang-Christensen M, Havel PJ, Jacobs RR, Larsen PJ, Cameron JL. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J Clin Endocrinol Metab. 1999;84(2):711–7.PubMed Tang-Christensen M, Havel PJ, Jacobs RR, Larsen PJ, Cameron JL. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J Clin Endocrinol Metab. 1999;84(2):711–7.PubMed
40.
Zurück zum Zitat Matsumura K, Abe I, Tsuchihashi T, Fujishima M. Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am J Physiol Regul Integr Comp Physiol. 2000;278(5):R1314–20.PubMed Matsumura K, Abe I, Tsuchihashi T, Fujishima M. Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am J Physiol Regul Integr Comp Physiol. 2000;278(5):R1314–20.PubMed
41.
Zurück zum Zitat Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens. 2002;20(7):1245–50.PubMedCrossRef Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens. 2002;20(7):1245–50.PubMedCrossRef
42.
Zurück zum Zitat Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A. 1997;94(16):8878–83.PubMedCentralPubMedCrossRef Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A. 1997;94(16):8878–83.PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Rahmouni K, Haynes WG, Morgan DA, Mark AL. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension. 2002;39(2 Part 2 Suppl S):486–90.PubMedCrossRef Rahmouni K, Haynes WG, Morgan DA, Mark AL. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension. 2002;39(2 Part 2 Suppl S):486–90.PubMedCrossRef
44.
Zurück zum Zitat Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000;105(9):1243–52.PubMedCentralPubMedCrossRef Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000;105(9):1243–52.PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Tumer N, Erdos B, Matheny M, Cudykier I, Scarpace PJ. Leptin antagonist reverses hypertension caused by leptin overexpression, but fails to normalize obesity-related hypertension. J Hypertens. 2007;25(12):2471–8.PubMedCrossRef Tumer N, Erdos B, Matheny M, Cudykier I, Scarpace PJ. Leptin antagonist reverses hypertension caused by leptin overexpression, but fails to normalize obesity-related hypertension. J Hypertens. 2007;25(12):2471–8.PubMedCrossRef
46.
Zurück zum Zitat Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension. 2010;56(3):351–8.PubMedCrossRef Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension. 2010;56(3):351–8.PubMedCrossRef
47.
Zurück zum Zitat Alsmadi O, Melhem M, Hebbar P, Thareja G, John SE, Alkayal F, et al. Leptin in association with common variants of MC3R mediates hypertension. Am J Hypertens. 2014;27(7):973–81.PubMedCrossRef Alsmadi O, Melhem M, Hebbar P, Thareja G, John SE, Alkayal F, et al. Leptin in association with common variants of MC3R mediates hypertension. Am J Hypertens. 2014;27(7):973–81.PubMedCrossRef
48.
Zurück zum Zitat Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med. 2009;360(1):44–52.PubMedCrossRef Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med. 2009;360(1):44–52.PubMedCrossRef
49.
Zurück zum Zitat Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension. 2005;46(2):326–32.PubMedCrossRef Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension. 2005;46(2):326–32.PubMedCrossRef
50.
Zurück zum Zitat Dubinion JH, da Silva AA, Hall JE. Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity. J Hypertens. 2010;28(7):1466–70.PubMedCentralPubMedCrossRef Dubinion JH, da Silva AA, Hall JE. Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity. J Hypertens. 2010;28(7):1466–70.PubMedCentralPubMedCrossRef
51.
Zurück zum Zitat Matsumura K, Tsuchihashi T, Abe I, Iida M. Central alpha-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits. Brain Res. 2002;948(1–2):145–8.PubMedCrossRef Matsumura K, Tsuchihashi T, Abe I, Iida M. Central alpha-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits. Brain Res. 2002;948(1–2):145–8.PubMedCrossRef
52.
Zurück zum Zitat Li P, Cui BP, Zhang LL, Sun HJ, Liu TY, Zhu GQ. Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure. Exp Physiol. 2013;98(2):435–43.PubMedCrossRef Li P, Cui BP, Zhang LL, Sun HJ, Liu TY, Zhu GQ. Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure. Exp Physiol. 2013;98(2):435–43.PubMedCrossRef
53.
Zurück zum Zitat do Carmo JM, da Silva AA, Rushing JS, Hall JE. Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2012;302(5):R561–7.PubMedCentralPubMedCrossRef do Carmo JM, da Silva AA, Rushing JS, Hall JE. Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2012;302(5):R561–7.PubMedCentralPubMedCrossRef
55.
Zurück zum Zitat Holt SJ, York DA. Interaction of intracerebroventricular insulin and glucose in the regulation of the activity of sympathetic efferent nerves to brown adipose tissue in lean and obese Zucker rats. Brain Res. 1989;500(1–2):384–8.PubMedCrossRef Holt SJ, York DA. Interaction of intracerebroventricular insulin and glucose in the regulation of the activity of sympathetic efferent nerves to brown adipose tissue in lean and obese Zucker rats. Brain Res. 1989;500(1–2):384–8.PubMedCrossRef
56.
Zurück zum Zitat Muntzel M, Morgan D, Mark A, Johnson A. Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol. 1994;36:R1350–R35. Muntzel M, Morgan D, Mark A, Johnson A. Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol. 1994;36:R1350–R35.
57.
Zurück zum Zitat Cassaglia PA, Hermes SM, Aicher SA, Brooks VL. Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats. J Physiol. 2011;589(Pt 7):1643–62.PubMedCentralPubMedCrossRef Cassaglia PA, Hermes SM, Aicher SA, Brooks VL. Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats. J Physiol. 2011;589(Pt 7):1643–62.PubMedCentralPubMedCrossRef
58.
Zurück zum Zitat Pricher MP, Freeman KL, Brooks VL. Insulin in the brain increases gain of baroreflex control of heart rate and lumbar sympathetic nerve activity. Hypertension. 2008;51(2):514–20.PubMedCrossRef Pricher MP, Freeman KL, Brooks VL. Insulin in the brain increases gain of baroreflex control of heart rate and lumbar sympathetic nerve activity. Hypertension. 2008;51(2):514–20.PubMedCrossRef
59.
Zurück zum Zitat Morgan DA, Rahmouni K. Differential effects of insulin on sympathetic nerve activity in agouti obese mice. J Hypertens. 2010;28(9):1913–9. Morgan DA, Rahmouni K. Differential effects of insulin on sympathetic nerve activity in agouti obese mice. J Hypertens. 2010;28(9):1913–9.
60.
Zurück zum Zitat Dunbar JC, Lu H. Chronic intracerebroventricular insulin attenuates the leptin-mediated but not alpha melanocyte stimulating hormone increase in sympathetic and cardiovascular responses. Brain Res Bull. 2000;52(2):123–6.PubMedCrossRef Dunbar JC, Lu H. Chronic intracerebroventricular insulin attenuates the leptin-mediated but not alpha melanocyte stimulating hormone increase in sympathetic and cardiovascular responses. Brain Res Bull. 2000;52(2):123–6.PubMedCrossRef
61.
Zurück zum Zitat Palatini P, Majahalme S, Amerena J, Nesbitt S, Vriz O, Michieletto M, et al. Determinants of left ventricular structure and mass in young subjects with sympathetic over-activity. The Tecumseh Offspring Study. J Hypertens. 2000;18(6):769–75.PubMedCrossRef Palatini P, Majahalme S, Amerena J, Nesbitt S, Vriz O, Michieletto M, et al. Determinants of left ventricular structure and mass in young subjects with sympathetic over-activity. The Tecumseh Offspring Study. J Hypertens. 2000;18(6):769–75.PubMedCrossRef
62.
Zurück zum Zitat Carroll JF, Dwyer TM, Grady AW, Reinhart GA, Montani JP, Cockrell K, et al. Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity. Am J Physiol Heart Circ Physiol. 1996;271(1 Pt 2):H373–8. Carroll JF, Dwyer TM, Grady AW, Reinhart GA, Montani JP, Cockrell K, et al. Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity. Am J Physiol Heart Circ Physiol. 1996;271(1 Pt 2):H373–8.
63.
Zurück zum Zitat Burke SL, Head GA. Method for in vivo calibration of renal sympathetic nerve activity in rabbits. J Neurosci Methods. 2003;127:63–74.PubMedCrossRef Burke SL, Head GA. Method for in vivo calibration of renal sympathetic nerve activity in rabbits. J Neurosci Methods. 2003;127:63–74.PubMedCrossRef
63.••
Zurück zum Zitat Burke SL, Prior LJ, Lukoshkova EV, Lim K, Barzel B, Davern P, et al. Reduced preprandial dipping accounts for rapid elevation of blood pressure and renal sympathetic nerve activity in rabbits fed a high-fat diet. Chronobiol Int. 2013;30(5):726–38. This study identified that elevated blood pressure induced by a high-fat diet from the first day is mediated by increased sympathetic nerve activity due to a reduction in preprandial dipping and that increased calories, glucose, insulin, and leptin may account for early changes whilst lon- term loss of dipping may be related to increased sensitivity of sympathetic pathways.PubMedCrossRef Burke SL, Prior LJ, Lukoshkova EV, Lim K, Barzel B, Davern P, et al. Reduced preprandial dipping accounts for rapid elevation of blood pressure and renal sympathetic nerve activity in rabbits fed a high-fat diet. Chronobiol Int. 2013;30(5):726–38. This study identified that elevated blood pressure induced by a high-fat diet from the first day is mediated by increased sympathetic nerve activity due to a reduction in preprandial dipping and that increased calories, glucose, insulin, and leptin may account for early changes whilst lon- term loss of dipping may be related to increased sensitivity of sympathetic pathways.PubMedCrossRef
65.
Zurück zum Zitat Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani J-P, et al. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2010;55(4):862–8.PubMedCrossRef Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani J-P, et al. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2010;55(4):862–8.PubMedCrossRef
66.
Zurück zum Zitat Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81(2):341–54.PubMed Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81(2):341–54.PubMed
67.
Zurück zum Zitat Jones DW. Body weight and blood pressure. Effects of weight reduction on hypertension. Am J Hypertens. 1996;9(8):50s–4.PubMedCrossRef Jones DW. Body weight and blood pressure. Effects of weight reduction on hypertension. Am J Hypertens. 1996;9(8):50s–4.PubMedCrossRef
68.
Zurück zum Zitat Carroll JF, Huang M, Hester RL, Cockrell K, Mizelle HL. Hemodynamic alterations in hypertensive obese rabbits. Hypertension. 1995;26(3):465–70.PubMedCrossRef Carroll JF, Huang M, Hester RL, Cockrell K, Mizelle HL. Hemodynamic alterations in hypertensive obese rabbits. Hypertension. 1995;26(3):465–70.PubMedCrossRef
69.
Zurück zum Zitat Carroll JF, Summers RL, Dzielak DJ, Cockrell K, Montani JP, Mizelle HL. Diastolic compliance is reduced in obese rabbits. Hypertension. 1999;33(3):811–5.PubMedCrossRef Carroll JF, Summers RL, Dzielak DJ, Cockrell K, Montani JP, Mizelle HL. Diastolic compliance is reduced in obese rabbits. Hypertension. 1999;33(3):811–5.PubMedCrossRef
70.
Zurück zum Zitat Antic V, Kiener-Belforti F, Tempini A, Montani J-P. Obesity-induced hypertension in rabbits is not salt-sensitive. J Hypertens. 1999;17 Suppl 3:S209. Antic V, Kiener-Belforti F, Tempini A, Montani J-P. Obesity-induced hypertension in rabbits is not salt-sensitive. J Hypertens. 1999;17 Suppl 3:S209.
71.
Zurück zum Zitat Taylor PD, Samuelsson AM, Poston L. Maternal obesity and the developmental programming of hypertension: a role for leptin. Acta Physiol (Oxf). 2014;210(3):508–23.CrossRef Taylor PD, Samuelsson AM, Poston L. Maternal obesity and the developmental programming of hypertension: a role for leptin. Acta Physiol (Oxf). 2014;210(3):508–23.CrossRef
72.
Zurück zum Zitat Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010;140(3):365–71.PubMedCrossRef Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010;140(3):365–71.PubMedCrossRef
73.
Zurück zum Zitat Meehan S, Beck CR, Mair-Jenkins J, Leonardi-Bee J, Puleston R. Maternal obesity and infant mortality: a meta-analysis. Pediatrics. 2014 Meehan S, Beck CR, Mair-Jenkins J, Leonardi-Bee J, Puleston R. Maternal obesity and infant mortality: a meta-analysis. Pediatrics. 2014
74.
Zurück zum Zitat Velkoska E, Cole TJ, Morris MJ. Early dietary intervention: long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers. Am J Physiol Endocrinol Metab. 2005;288(6):E1236–43.PubMedCrossRef Velkoska E, Cole TJ, Morris MJ. Early dietary intervention: long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers. Am J Physiol Endocrinol Metab. 2005;288(6):E1236–43.PubMedCrossRef
74.••
Zurück zum Zitat Prior L, Davern P, Burke S, Lim K, Armitage J, Head G. Exposure to a high fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2014;63(2):338–45. This landmark study revealed that offspring from mothers consuming a high-fat diet exhibit an adverse cardiovascular profile in adulthood including hypertension and increased renal sympathetic activity due to altered central hypothalamic sensitivity to leptin and ghrelin. Faculty of 1000 recommendation.PubMedCrossRef Prior L, Davern P, Burke S, Lim K, Armitage J, Head G. Exposure to a high fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2014;63(2):338–45. This landmark study revealed that offspring from mothers consuming a high-fat diet exhibit an adverse cardiovascular profile in adulthood including hypertension and increased renal sympathetic activity due to altered central hypothalamic sensitivity to leptin and ghrelin. Faculty of 1000 recommendation.PubMedCrossRef
76.
Zurück zum Zitat Henry SL, Barzel B, Burke SL, Head GA, Armitage JA. Developmental origins of obesity related hypertension. Clin Exp Pharmacol Physiol. 2012;39:799–806.PubMedCrossRef Henry SL, Barzel B, Burke SL, Head GA, Armitage JA. Developmental origins of obesity related hypertension. Clin Exp Pharmacol Physiol. 2012;39:799–806.PubMedCrossRef
77.
Zurück zum Zitat Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth. 2010;10:56.PubMedCentralPubMedCrossRef Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth. 2010;10:56.PubMedCentralPubMedCrossRef
78.
Zurück zum Zitat Barzel B, Burke S, Armitage J, Head G, editors. Alpha melanocortin stimulating hormone actions at the ventromedial hypothalamus increase renal sympathetic actvity in fat fed rabbits. Experimental Biology; 2013 April 2013; Boston, USA. Barzel B, Burke S, Armitage J, Head G, editors. Alpha melanocortin stimulating hormone actions at the ventromedial hypothalamus increase renal sympathetic actvity in fat fed rabbits. Experimental Biology; 2013 April 2013; Boston, USA.
79.
Zurück zum Zitat Epel ES, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell KD, et al. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med. 2000;62(5):623–32.PubMedCrossRef Epel ES, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell KD, et al. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med. 2000;62(5):623–32.PubMedCrossRef
80.
Zurück zum Zitat Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev. 2001;2(2):73–86.PubMedCrossRef Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev. 2001;2(2):73–86.PubMedCrossRef
81.
Zurück zum Zitat Lambert E, Dawood T, Straznicky N, Sari C, Schlaich M, Esler M, et al. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens. 2010;28(3):543–50.PubMedCrossRef Lambert E, Dawood T, Straznicky N, Sari C, Schlaich M, Esler M, et al. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens. 2010;28(3):543–50.PubMedCrossRef
82.
Zurück zum Zitat Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17(8):1125–33.PubMedCrossRef Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17(8):1125–33.PubMedCrossRef
83.
Zurück zum Zitat Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, et al. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Metab Clin Exp. 1996;45(3):351–6.PubMedCrossRef Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, et al. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Metab Clin Exp. 1996;45(3):351–6.PubMedCrossRef
84.
Zurück zum Zitat Kuniyoshi FHS, Trombetta IC, Batalha LT, Rondon M, Laterza MC, Gowdak MMG, et al. Abnormal neurovascular control during sympathoexcitation in obesity. Obes Res. 2003;11(11):1411–9.PubMedCrossRef Kuniyoshi FHS, Trombetta IC, Batalha LT, Rondon M, Laterza MC, Gowdak MMG, et al. Abnormal neurovascular control during sympathoexcitation in obesity. Obes Res. 2003;11(11):1411–9.PubMedCrossRef
85.
Zurück zum Zitat Carroll D, Phillips AC, Der G. Body mass index, abdominal adiposity, obesity, and cardiovascular reactions to psychological stress in a large community sample. Psychosom Med. 2008;70(6):653–60.PubMedCrossRef Carroll D, Phillips AC, Der G. Body mass index, abdominal adiposity, obesity, and cardiovascular reactions to psychological stress in a large community sample. Psychosom Med. 2008;70(6):653–60.PubMedCrossRef
86.
Zurück zum Zitat Korner P. Essential hypertension and its causes: neural and non neural mechanisms. New York: Oxford University Press; 2007. Korner P. Essential hypertension and its causes: neural and non neural mechanisms. New York: Oxford University Press; 2007.
87.
Zurück zum Zitat Elmquist JK. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol Behav. 2001;74(4–5):703–8.PubMedCrossRef Elmquist JK. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol Behav. 2001;74(4–5):703–8.PubMedCrossRef
88.
Zurück zum Zitat Marsh AJ, Fontes MA, Killinger S, Pawlak DB, Polson JW, Dampney RA. Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension. 2003;42(4):488–93.PubMedCrossRef Marsh AJ, Fontes MA, Killinger S, Pawlak DB, Polson JW, Dampney RA. Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension. 2003;42(4):488–93.PubMedCrossRef
89.
Zurück zum Zitat McDougall SJ, Widdop RE, Lawrence AJ. Central autonomic integration of psychological stressors: focus on cardiovascular modulation. Auton Neurosci. 2005;123(1–2):1–11.PubMedCrossRef McDougall SJ, Widdop RE, Lawrence AJ. Central autonomic integration of psychological stressors: focus on cardiovascular modulation. Auton Neurosci. 2005;123(1–2):1–11.PubMedCrossRef
90.
Zurück zum Zitat De Matteo R, Head GA, Mayorov DN. Angiotensin II in dorsomedial hypothalamus modulates cardiovascular arousal caused by stress but not feeding in rabbits. Am J Physiol Regul Integr Comp Physiol. 2006;290(1):R257–64.PubMedCrossRef De Matteo R, Head GA, Mayorov DN. Angiotensin II in dorsomedial hypothalamus modulates cardiovascular arousal caused by stress but not feeding in rabbits. Am J Physiol Regul Integr Comp Physiol. 2006;290(1):R257–64.PubMedCrossRef
Metadaten
Titel
Central Nervous System Dysfunction in Obesity-Induced Hypertension
verfasst von
Geoffrey A. Head
Kyungjoon Lim
Benjamin Barzel
Sandra L. Burke
Pamela J. Davern
Publikationsdatum
01.09.2014
Verlag
Springer US
Erschienen in
Current Hypertension Reports / Ausgabe 9/2014
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-014-0466-4

Weitere Artikel der Ausgabe 9/2014

Current Hypertension Reports 9/2014 Zur Ausgabe

Hypertension and the Brain (S Stocker, Section Editor)

Chemoreflexes, Sleep Apnea, and Sympathetic Dysregulation

Hypertension and the Kidney (RM Carey, Section Editor)

Renal Generation of Angiotensin II and the Pathogenesis of Hypertension

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.